318 related articles for article (PubMed ID: 29450620)
1. Targeting the neddylation pathway in cells as a potential therapeutic approach for diseases.
Ying J; Zhang M; Qiu X; Lu Y
Cancer Chemother Pharmacol; 2018 May; 81(5):797-808. PubMed ID: 29450620
[TBL] [Abstract][Full Text] [Related]
2. Cullin-RING Ligases as attractive anti-cancer targets.
Zhao Y; Sun Y
Curr Pharm Des; 2013; 19(18):3215-25. PubMed ID: 23151137
[TBL] [Abstract][Full Text] [Related]
3. Targeting Neddylation pathways to inactivate cullin-RING ligases for anticancer therapy.
Zhao Y; Morgan MA; Sun Y
Antioxid Redox Signal; 2014 Dec; 21(17):2383-400. PubMed ID: 24410571
[TBL] [Abstract][Full Text] [Related]
4. Targeting neddylation in cancer therapy.
Duncan K; Schäfer G; Vava A; Parker MI; Zerbini LF
Future Oncol; 2012 Nov; 8(11):1461-70. PubMed ID: 23148618
[TBL] [Abstract][Full Text] [Related]
5. Targeting NEDD8-activated cullin-RING ligases for the treatment of cancer.
Soucy TA; Smith PG; Rolfe M
Clin Cancer Res; 2009 Jun; 15(12):3912-6. PubMed ID: 19509147
[TBL] [Abstract][Full Text] [Related]
6. Cullin 5-RING E3 ubiquitin ligases, new therapeutic targets?
Lamsoul I; Uttenweiler-Joseph S; Moog-Lutz C; Lutz PG
Biochimie; 2016 Mar; 122():339-47. PubMed ID: 26253693
[TBL] [Abstract][Full Text] [Related]
7. Targeting Protein Neddylation for Cancer Therapy.
Zhou L; Jia L
Adv Exp Med Biol; 2020; 1217():297-315. PubMed ID: 31898235
[TBL] [Abstract][Full Text] [Related]
8. Introduction.
Sun Y
Adv Exp Med Biol; 2020; 1217():1-8. PubMed ID: 31898218
[TBL] [Abstract][Full Text] [Related]
9. NEDD8-its role in the regulation of Cullin-RING ligases.
Schwechheimer C
Curr Opin Plant Biol; 2018 Oct; 45(Pt A):112-119. PubMed ID: 29909289
[TBL] [Abstract][Full Text] [Related]
10. Flavokawain B targets protein neddylation for enhancing the anti-prostate cancer effect of Bortezomib via Skp2 degradation.
Li X; Pham V; Tippin M; Fu D; Rendon R; Song L; Uchio E; Hoang BH; Zi X
Cell Commun Signal; 2019 Mar; 17(1):25. PubMed ID: 30885218
[TBL] [Abstract][Full Text] [Related]
11. Coupled monoubiquitylation of the co-E3 ligase DCNL1 by Ariadne-RBR E3 ubiquitin ligases promotes cullin-RING ligase complex remodeling.
Kelsall IR; Kristariyanto YA; Knebel A; Wood NT; Kulathu Y; Alpi AF
J Biol Chem; 2019 Feb; 294(8):2651-2664. PubMed ID: 30587576
[TBL] [Abstract][Full Text] [Related]
12. Nedd8-Activating Enzyme Is a Druggable Host Dependency Factor of Human and Mouse Cytomegalovirus.
Flores-Martínez YA; Le-Trilling VTK; Trilling M
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452475
[TBL] [Abstract][Full Text] [Related]
13. Cullin-RING E3 Ubiquitin Ligases: Bridges to Destruction.
Nguyen HC; Wang W; Xiong Y
Subcell Biochem; 2017; 83():323-347. PubMed ID: 28271482
[TBL] [Abstract][Full Text] [Related]
14. Cullin neddylation inhibitor attenuates hyperglycemia by enhancing hepatic insulin signaling through insulin receptor substrate stabilization.
Chen C; Gu L; Matye DJ; Clayton YD; Hasan MN; Wang Y; Friedman JE; Li T
Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35115401
[TBL] [Abstract][Full Text] [Related]
15. Targeting DCN1-UBC12 Protein-Protein Interaction for Regulation of Neddylation Pathway.
Zhou H; Lu J; Yang CY; Sun Y; Wang S
Adv Exp Med Biol; 2020; 1217():349-362. PubMed ID: 31898237
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitination of NKCC2 by the cullin-RING E3 ubiquitin ligase family in the thick ascending limb of the loop of Henle.
Ares GR
Am J Physiol Renal Physiol; 2023 Mar; 324(3):F315-F328. PubMed ID: 36727946
[TBL] [Abstract][Full Text] [Related]
17. Diverse and pivotal roles of neddylation in metabolism and immunity.
Zou T; Zhang J
FEBS J; 2021 Jul; 288(13):3884-3912. PubMed ID: 33025631
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases.
Villeneuve NF; Lau A; Zhang DD
Antioxid Redox Signal; 2010 Dec; 13(11):1699-712. PubMed ID: 20486766
[TBL] [Abstract][Full Text] [Related]
19. Targeting cullin neddylation for cancer and fibrotic diseases.
He ZX; Yang WG; Zengyangzong D; Gao G; Zhang Q; Liu HM; Zhao W; Ma LY
Theranostics; 2023; 13(14):5017-5056. PubMed ID: 37771770
[TBL] [Abstract][Full Text] [Related]
20. Targeting cullin-RING ligases for cancer treatment: rationales, advances and therapeutic implications.
Wu S; Yu L
Cytotechnology; 2016 Jan; 68(1):1-8. PubMed ID: 25899169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
